Biobeat vs Sickbay
Two very different answers to the same gap, which is that ward patients are barely monitored between checks. Biobeat changes what data exists, putting wearable continuous monitors on patients and generating vital signs that were never collected, with a genuinely strong progressive clearance record for cuffless measurement and the widest setting coverage in this category. Sickbay changes what can be done with the data that already exists, serving high resolution physiologic capture as a vendor neutral layer that any algorithm can run on. A hospital may need both, and the question is which gap binds: no data, or data nobody can use. On Biobeat, the question to press is skin tone, because optical measurement performs differently across pigmentation and no subgroup analysis is published for a device driving automated alerts.
- It changes what data exists rather than modelling data that already does, with wearable continuous monitoring bringing vital signs to patients who are otherwise checked intermittently.
- The regulatory record is progressively built and genuinely strong across a series of clearances for cuffless measurement.
- Setting coverage is the widest in this category by design, spanning general wards, step down and home settings on one platform.
- It is the vendor neutral physiologic data layer that risk models run on, rather than a model or a device, so the institution is not locked to one algorithm.
- High resolution physiologic capture is the harder engineering problem underneath every deterioration model in the unit.
- Buying the layer separately means algorithms can be replaced without replacing the plumbing, which is the durable architectural position.
Side by Side
| Axis | B Biobeat |
S Sickbay |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
The pigmentation problem is at its sharpest in this pair and only one side carries it: optical vital sign measurement is known to perform differently across skin tones, and Biobeat publishes no subgroup performance analysis for a device whose measurements drive automated early warning alerts. Ask for it explicitly. Neither vendor publishes pricing or a unit of pricing such as per monitored bed. Biobeat publishes no named record system integration, no attestation and no retention position, and its early warning score has no published threshold or alert burden figure.